Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Brain : a Journal of Neurology
|
March 2, 2002
Clinical predictive factors of subthalamic stimulation in Parkinson's disease
M L Welter, J L Houeto, S Tezenas du Montcel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Neurology
|
September 22, 2010
Low disease risk in relatives of north african lrrk2 Parkinson disease patients
A R Troiano, A Elbaz, E Lohmann, et al.
Neurology
|
May 11, 2005
Parkinson disease, brain volumes, and subthalamic nucleus stimulation
F Bonneville, M L Welter, C Elie, et al.
Advances in Neurology
|
November 22, 2002
Parkinson's disease is a neuropsychiatric disorder
Y Agid, I Arnulf, P Bejjani, et al.
Revue Neurologique
|
February 5, 2017
"De-novo" consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes
J Ruggeri, L-L Mariani, S Aix, et al.
Brain : a Journal of Neurology
|
May 29, 2000
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
J Tassin, A Dürr, A M Bonnet, et al.
Neurology
|
December 8, 2006
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial
W M M Schüpbach, D Maltête, J L Houeto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 18, 2005
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up
W M M Schüpbach, N Chastan, M L Welter, et al.
American Journal of Human Genetics
|
June 23, 1998
Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease
J Tassin, A Dürr, T de Broucker, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Brain : a Journal of Neurology
|
March 2, 2002
Clinical predictive factors of subthalamic stimulation in Parkinson's disease
M L Welter, J L Houeto, S Tezenas du Montcel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Neurology
|
September 22, 2010
Low disease risk in relatives of north african lrrk2 Parkinson disease patients
A R Troiano, A Elbaz, E Lohmann, et al.
Neurology
|
May 11, 2005
Parkinson disease, brain volumes, and subthalamic nucleus stimulation
F Bonneville, M L Welter, C Elie, et al.
Advances in Neurology
|
November 22, 2002
Parkinson's disease is a neuropsychiatric disorder
Y Agid, I Arnulf, P Bejjani, et al.
Revue Neurologique
|
February 5, 2017
"De-novo" consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes
J Ruggeri, L-L Mariani, S Aix, et al.
Brain : a Journal of Neurology
|
May 29, 2000
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
J Tassin, A Dürr, A M Bonnet, et al.
Neurology
|
December 8, 2006
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial
W M M Schüpbach, D Maltête, J L Houeto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 18, 2005
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up
W M M Schüpbach, N Chastan, M L Welter, et al.
American Journal of Human Genetics
|
June 23, 1998
Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease
J Tassin, A Dürr, T de Broucker, et al.
Page
of 10